NM_006059.4:c.1792G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006059.4(LAMC3):​c.1792G>A​(p.Gly598Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00268 in 1,613,700 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0098 ( 17 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 19 hom. )

Consequence

LAMC3
NM_006059.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.74

Publications

7 publications found
Variant links:
Genes affected
LAMC3 (HGNC:6494): (laminin subunit gamma 3) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 3. The gamma 3 chain is most similar to the gamma 1 chain, and contains all the 6 domains expected of the gamma chain. It is a component of laminin 12. The gamma 3 chain is broadly expressed in skin, heart, lung, and the reproductive tracts. In skin, it is seen within the basement membrane of the dermal-epidermal junction at points of nerve penetration. Gamma 3 is also a prominent element of the apical surface of ciliated epithelial cells of lung, oviduct, epididymis, ductus deferens, and seminiferous tubules. The distribution of gamma 3-containing laminins along ciliated epithelial surfaces suggests that the apical laminins are important in the morphogenesis and structural stability of the ciliated processes of these cells. [provided by RefSeq, Aug 2011]
LAMC3 Gene-Disease associations (from GenCC):
  • occipital pachygyria and polymicrogyria
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, Illumina
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036583543).
BP6
Variant 9-131052652-G-A is Benign according to our data. Variant chr9-131052652-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 129453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00977 (1487/152248) while in subpopulation AFR AF = 0.0264 (1095/41540). AF 95% confidence interval is 0.0251. There are 17 homozygotes in GnomAd4. There are 696 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMC3NM_006059.4 linkc.1792G>A p.Gly598Arg missense_variant Exon 10 of 28 ENST00000361069.9 NP_006050.3 Q9Y6N6Q8N2D6
LAMC3XM_011518121.2 linkc.1792G>A p.Gly598Arg missense_variant Exon 10 of 28 XP_011516423.1
LAMC3XM_006716921.3 linkc.1792G>A p.Gly598Arg missense_variant Exon 10 of 23 XP_006716984.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMC3ENST00000361069.9 linkc.1792G>A p.Gly598Arg missense_variant Exon 10 of 28 2 NM_006059.4 ENSP00000354360.4 Q9Y6N6

Frequencies

GnomAD3 genomes
AF:
0.00978
AC:
1488
AN:
152130
Hom.:
17
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0265
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0151
Gnomad ASJ
AF:
0.00433
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00138
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00337
AC:
841
AN:
249576
AF XY:
0.00287
show subpopulations
Gnomad AFR exome
AF:
0.0253
Gnomad AMR exome
AF:
0.00626
Gnomad ASJ exome
AF:
0.00469
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00136
Gnomad OTH exome
AF:
0.00295
GnomAD4 exome
AF:
0.00194
AC:
2832
AN:
1461452
Hom.:
19
Cov.:
35
AF XY:
0.00182
AC XY:
1323
AN XY:
727016
show subpopulations
African (AFR)
AF:
0.0276
AC:
923
AN:
33474
American (AMR)
AF:
0.00635
AC:
284
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00394
AC:
103
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53242
Middle Eastern (MID)
AF:
0.00751
AC:
43
AN:
5728
European-Non Finnish (NFE)
AF:
0.00108
AC:
1198
AN:
1111856
Other (OTH)
AF:
0.00441
AC:
266
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
161
322
482
643
804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00977
AC:
1487
AN:
152248
Hom.:
17
Cov.:
33
AF XY:
0.00935
AC XY:
696
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0264
AC:
1095
AN:
41540
American (AMR)
AF:
0.0152
AC:
232
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00433
AC:
15
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00138
AC:
94
AN:
68000
Other (OTH)
AF:
0.0132
AC:
28
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
71
142
214
285
356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00407
Hom.:
12
Bravo
AF:
0.0108
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0241
AC:
106
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00349
AC:
424
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00234
EpiControl
AF:
0.00196

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 27, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Aug 05, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 24, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

LAMC3-related disorder Benign:1
May 14, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
10
DANN
Benign
0.53
DEOGEN2
Benign
0.030
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.33
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L
PhyloP100
1.7
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.062
Sift
Benign
0.59
T
Sift4G
Benign
0.62
T
Polyphen
0.014
B
Vest4
0.14
MutPred
0.49
Gain of solvent accessibility (P = 0.0789);
MVP
0.46
MPC
0.19
ClinPred
0.0042
T
GERP RS
2.4
Varity_R
0.055
gMVP
0.46
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116422150; hg19: chr9-133928039; API